Infex Therapeutics is pushing…
Infex Therapeutics is pushing ahead with development of a non-cystic [...]
Several biotech contracts are…
Several biotech contracts are rotating through Kalshi and Polymarket, while [...]
As an outbreak of Ebola in central…
As an outbreak of Ebola in central Africa continues to [...]
San Carlos-based Engage is…
San Carlos-based Engage is developing non-viral DNA delivery systems that [...]
In the sprawling metropolis of…
In the sprawling metropolis of Houston, a new biotech has [...]
Incyte and Edison Scientific have…
Incyte and Edison Scientific have signed a collaboration to employ [...]
Exelixis has secured supplies of…
Exelixis has secured supplies of subcutaneous Keytruda from Merck & [...]
Relay Therapeutics’ R&D…
Relay Therapeutics’ R&D chief remains convinced the biotech’s PI3Kα inhibitor [...]
Sanofi and Wave Life Sciences are…
Sanofi and Wave Life Sciences are using their time at [...]
BioMarin’s $270 million bet on…
BioMarin’s $270 million bet on Inozyme’s enzyme replacement therapy looks [...]